Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Clarifies 510(k) Review Clock Policy In MDUFMA Guidance

This article was originally published in The Gray Sheet

Executive Summary

FDA will allow extensions of up to 90 days for firms to respond to additional information (AI) requests, the agency explains in a guidance document on 510(k) user fee performance goals

You may also be interested in...



Reprocessed single-use devices

FDA will allow 30 days for SUD reprocessors to respond to additional-information letters concerning 510(k) Supplemental Validation Submissions, but will not grant time extensions, according to 1revised guidance issued May 27. "Manufacturers should have this validation information readily available since the reprocessed device(s) are currently marketed and such data should have been developed and maintained" under QS requirements, FDA reasons. Original 510(k) applicants, by contrast, are allowed 90-day extensions to respond to AI letters (2"The Gray Sheet" May 24, 2004, p. 10). The reprocessor 510(k) data validation guidance supersedes a July 2003 document...

510(k) User Fee Exemptions, Refund Guidelines Explained In Guidance

Premarket notification submissions reviewed by European Union Conformity Assessment Bodies will be exempt from user fees

Reprocessed single-use devices

FDA will allow 30 days for SUD reprocessors to respond to additional-information letters concerning 510(k) Supplemental Validation Submissions, but will not grant time extensions, according to 1revised guidance issued May 27. "Manufacturers should have this validation information readily available since the reprocessed device(s) are currently marketed and such data should have been developed and maintained" under QS requirements, FDA reasons. Original 510(k) applicants, by contrast, are allowed 90-day extensions to respond to AI letters (2"The Gray Sheet" May 24, 2004, p. 10). The reprocessor 510(k) data validation guidance supersedes a July 2003 document...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020274

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel